ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 105014 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 105014; 2) Community: the network communities that were significantly associated with the response to NSC 105014; 3) Molecule: the relationships between components within communities and NSC 105014; 4) MDR: the compounds that were significantly associated with the NSC 105014.

NSC Compound Enrichment Correlation
NSC 683555 Camptothecin Derivative 0.000931492155975116 0.58836456
NSC 691037 Null 0.000931492155975116 0.32854313
NSC 724003 5-Chloro-pyrazine-2-carboxylic acid benzylamide 0.000931492155975116 0.15822603
NSC 107124 Camptothecin Derivative 0.00094423800811012 0.5598591
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.00094423800811012 0.44331302
NSC 716211 Null 0.00094423800811012 0.2805612
NSC 681646 Camptothecin Derivative 0.00103112124545269 0.54565213
NSC 683140 Null 0.00103112124545269 0.35145071
NSC 122060 Ethanesulfonic acid, compd. with N-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy]propyl]carbamoyl]metanilyl fluoride (1:1) (8CI) (MF2) 0.00115116014164088 0.078420829
NSC 20527 5-Bromosalicylic acid p-bromoanilide 0.00115116014164088 0.092852265
Total:75  Current:4    [First] [Prev] [Next] [Last]